Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | ATRC-101 |
Trade Name | |
Synonyms | ATRC101|ATRC 101 |
Drug Descriptions |
ATRC-101 is a monoclonal antibody targeting the ribonucleoprotein complex to stimulate an anti-tumor response (NCI Thesaurus). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C172924 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
ATRC-101 | ATRC-101 | 0 | 1 |
ATRC-101 + Pembrolizumab | ATRC-101 Pembrolizumab | 0 | 0 |